CAS: 1510712-69-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl] REF: 3D-KKC71269CAS: 1510712-69-2 | Min. 95% | To inquire | Tue 18 Feb 25 | |
CL264 REF: TM-T10833CAS: 1510712-69-2 | 97.14% | 53.00 €~1,820.00 € | Tue 25 Feb 25 |
Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl]
CAS:1510712-69-2
Please enquire for more information about Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl] including the price, delivery time and more detailed …
Formula:
C19H23N7O4
Purity:
Min. 95%
Molecular weight:
413.4 g/mol
Ref: 3D-KKC71269
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
CL264
CAS:1510712-69-2
CL264, a selective agonist of TLR7, can be used in studies about innate immune signals.
Formula:
C19H23N7O4
Purity:
97.14%
Color and Shape:
Solid
Molecular weight:
413.43
Ref: TM-T10833
1mg | 53.00 € | ||
5mg | 118.00 € | ||
10mg | 195.00 € | ||
25mg | 308.00 € | ||
50mg | 426.00 € | ||
100mg | 567.00 € | ||
200mg | 765.00 € | ||
1mL*10mM (DMSO) | 130.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025